Skip to main content

Development and validation of rapid molecular diagnostic test for nCoV19

Objectif

Rapid development of a molecular diagnostic test for Corona virus nCoV19 for near patient testing

Champ scientifique

  • /sciences médicales et de la santé/sciences de la santé/maladies infectieuses/virus à ARN/coronavirus

Appel à propositions

H2020-SC1-PHE-CORONAVIRUS-2020
Voir d’autres projets de cet appel

Régime de financement

RIA - Research and Innovation action
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinateur

HIBERGENE DIAGNOSTICS LIMITED
Adresse
21 Palmerstown Gardens, Rathmines
DUBLIN 6 Dublin
Irlande
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contribution de l’UE
€ 643 796,25

Participants (3)

THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom
Contribution de l’UE
€ 36 012,50
Adresse
University Road Lanyon Building
BT7 1NN Belfast
Type d’activité
Higher or Secondary Education Establishments
IRCCS OSPEDALE POLICLINICO SAN MARTINO
Italie
Contribution de l’UE
€ 61 875
Adresse
Largo Rosanna Benzi 10
16132 Genova
Type d’activité
Research Organisations
SHENZHEN MEDCAPTAIN MEDICAL TECHNOLOGY
Chine
Contribution de l’UE
€ 189 921
Adresse
5158 West Shahe Road 12Th Floor Baiwang Research Bulling 1 Xili Nanshan
518055 Shenzhen
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)